Carole A. Sable
Technik-/Wissenschafts-/F&E-Leiter bei VITAE PHARMACEUTICALS INC
Aktive Positionen von Carole A. Sable
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VITAE PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 06.06.2016 | - |
BASILEA PHARMACEUTICA AG | Direktor/Vorstandsmitglied | 27.04.2023 | - |
Karriereverlauf von Carole A. Sable
Ehemalige bekannte Positionen von Carole A. Sable
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SCYNEXIS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 | 20.02.2015 |
MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2010 | 01.01.2013 |
MERCK & CO., INC. | Corporate Officer/Principal | 01.01.1995 | 01.01.2007 |
University of Virginia | Corporate Officer/Principal | 01.01.1993 | 01.01.1995 |
REVOLUTION MEDICINES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.03.2015 | - |
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Carole A. Sable
Sidney Kimmel Medical College | Doctorate Degree |
Thomas Jefferson University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Frankreich | 2 |
Schweiz | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
SCYNEXIS, INC. | Health Technology |
REVOLUTION MEDICINES, INC. | Health Technology |
BASILEA PHARMACEUTICA AG | Health Technology |
Private Unternehmen | 2 |
---|---|
Novexel SA
Novexel SA Pharmaceuticals: MajorHealth Technology Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France. | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
- Börse
- Insiders
- Carole A. Sable
- Erfahrung